↓ Skip to main content

Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply

Overview of attention for article published in Trials, December 2009
Altmetric Badge

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply
Published in
Trials, December 2009
DOI 10.1186/1745-6215-10-111
Authors

Ian Roberts, Haleema Shakur

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 22%
Professor 1 11%
Professor > Associate Professor 1 11%
Student > Master 1 11%
Unknown 4 44%
Readers by discipline Count As %
Medicine and Dentistry 5 56%
Psychology 1 11%
Unknown 3 33%